Insurers Running Medicare Advantage Plans Overbill Taxpayers By Billions As Feds Struggle To Stop It
An enhanced government effort to catch insurers that overcharge Medicare faces resistance from the insurance industry.
Showing 61 - 80 of 89
-
-
Feds Want To Show Health Care Costs On Your Phone, But That Could Take Years
Giving consumers more knowledge about the costs of care has long been desired, but administration officials cautioned it could take two years or more for useful data to appear in a phone app.
By Fred Schulte -
Pain Clinics’ Doctors Needlessly Tested Hundreds Of Urine Samples, Court Records Show
Whistleblower lawsuits accuse Tennessee chain of bilking millions from Medicare for unnecessary urine drug tests.
By Fred Schulte -
New Rules Will Ease Patients’ Access To Electronic Medical Records, Senate Panel Says
Sen. Lamar Alexander (R-Tenn.), head of the influential HELP committee, wants to make it easier to share and store detailed medical histories.
By Fred Schulte and Erika Fry, Fortune -
FDA Chief Calls For Stricter Scrutiny Of Electronic Health Records
In an interview, FDA Commissioner Scott Gottlieb reacts to a KHN/Fortune investigation of the drawbacks and risks of electronic health records.
By Fred Schulte and Erika Fry, Fortune -
Five Things To Know About The Electronic Health Records Mess
The U.S. government claimed that ditching paper medical charts for electronic records would make health care better, safer and cheaper. Ten years and $36 billion later, the digital revolution has gone awry.
By Fred Schulte -
Death By 1,000 Clicks: Where Electronic Health Records Went Wrong
The U.S. government claimed that turning American medical charts into electronic records would make health care better, safer and cheaper. Ten years and $36 billion later, the system is an unholy mess. Inside a digital revolution that took a bad turn.
By Fred Schulte and Erika Fry, Fortune -
Feds Settle Huge Whistleblower Suit Over Medicare Advantage Fraud
A DaVita subsidiary will pay $270 million over allegations that it cheated the federal government for years.
By Fred Schulte -
Avoidable Sepsis Infections Send Thousands Of Seniors To Gruesome Deaths
No one tracks sepsis cases closely enough to know how often these severe infections turn fatal. But the toll — both human and financial — is enormous, finds an investigation by KHN and the Chicago Tribune.
-
Giuliani’s Consulting Firm Helped Halt Purdue Opioid Investigation In Florida
Post-9/11, Giuliani Partners helped craft a plan that put a halt to a probe into Purdue’s marketing of OxyContin.
By Fred Schulte -
Purdue Pharma’s Sales Pitch Downplayed Risks Of Opioid Addiction
Through a widely circulated brochure and a videotape of testimonials, the maker of OxyContin stressed patients’ right to opioid treatment for pain.
By Fred Schulte -
How Rival Opioid Makers Sought To Cash In On Alarm Over OxyContin’s Dangers
Fentanyl and other painkillers marketed as safer than Purdue Pharma’s blockbuster drug left their own trail of overdose deaths.
By Fred Schulte -
Purdue Pharma Edits Public Service Ad In Washington Post
Did OxyContin maker admit opioids can be dangerous even when patients take them as prescribed — then walk it back?
By Fred Schulte -
Tennessee-Based Pain Management Group To Close Clinics Amid Financial Turmoil
The CEO of Comprehensive Pain Specialists was indicted in April. Now the group is closing clinics across several states.
By Fred Schulte -
KHN EXCLUSIVE
How America Got Hooked On A Deadly Drug
An inside look at how Purdue Pharma pushed OxyContin despite risks of addiction and fatalities.
By Fred Schulte -
Bill Of The Month: A College Student’s $17,850 Drug Test
Kaiser Health News, in collaboration with NPR, kicks off a series that will examine and decode your perplexing medical bills.
By Fred Schulte -
Pain Hits After Surgery When A Doctor’s Daughter Is Stunned By $17,850 Urine Test
Elizabeth Moreno got hit with a $17,850 bill from a Texas lab after leaving a urine sample at her doctor’s office.
By Fred Schulte -
Medicare Fails To Recover Hundreds Of Millions Of Dollars In Lab Overcharges
Genetic testing firms declare bankruptcy and wipe out debt to the federal government.
By Fred Schulte -
Doctors Make Big Money Testing Urine For Drugs, Then Ignore Abnormal Results
Medicare and insurers struggle to oversee a booming business in testing urine samples. In some cases, pain doctors’ lack of follow-through can turn fatal.
By Fred Schulte -
Liquid Gold: Pain Doctors Soak Up Profits By Screening Urine For Drugs
With the nation's opioid crisis, urine testing has become a booming business and is especially lucrative for doctors who operate their own labs, a Kaiser Health News investigation finds. And dozens of practitioners have earned "the lion’s share" of their Medicare income exclusively from urine drug screens.
Sign Up For Our Newsletter
Stay informed by signing up for the Morning Briefing and other emails: